An irked President Trump is considering trade actions against Beijing. » Read More
President Donald Trump sounded an optimistic tone after Senate Republicans delayed a vote on their health-care bill.
Senate Republicans will delay a vote on their Obamacare replacement bill until after July 4.
Goldman Sachs tells its clients stock picking is getting more difficult, but investors can succeed by following this new, improved strategy.
The GOP will never be able to pass an Obamacare replacement bill until they do this one thing, says Jake Novak.
After a brief drop in Saudi oil exports in April and May, June crude loadings are back on the rise, according to ClipperData.
The scorching heat's on California and it's led to worries about citrus and nut crops as well as the state's dairy business.
Shares of Innate Immunotherapeutics tanked 92 percent to less than 5 Australian cents on Tuesday.
For the past four months, we've seen a medical system working to keep my son alive and a political system that's taking care away.
Learn the tricks that earn you loyal fans.
The FDA's new list — designed to spur generic competition to bring down prices or deter gougers — holds a big risk for Valeant.
Scaramucci, a Republican fundraiser, has been working at the Washington-based bank since the middle of June.
New York leads the world in the number of super-rich multimillionaires, though Hong Kong is catching up, according to a new report.
In the Halftime Report's inaugural stock survey, the street's top strategists share their predictions for 2H17.
More Americans will be left with zero to few insurers selling Obamacare health plans in 2018, CMS said.
Fed Chair Janet Yellen said Tuesday that banks are "very much stronger" judging by how major institutions did in the recent stress tests.
When the economy is running at full speed, shocks that may have had little impact during the early years can be catastrophic now.
One of Wall Street's biggest bulls has a key decision to make.
Senate Republicans delayed the vote on their health-care bill, but economist Austan Goolsbee told CNBC he believes the measure is doomed.
If implemented, the Senate Republican health-care bill may actually end up increasing costs compared to Obamacare, says consultant Robert Laszewski.